Search Results - "Phillips, Eli G."

Use of Real-World Evidence to Support FDA Approval of Oncology Drugs by Feinberg, Bruce A., Gajra, Ajeet, Zettler, Marjorie E., Phillips, Todd D., Phillips, Eli G., Kish, Jonathan K.

“…Real-world evidence (RWE) has gained increased attention in recent years as a complement to traditional clinical trials. The use of RWE to establish the…”
Get full text

Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years by Zettler, Marjorie E., Feinberg, Bruce A., Phillips Jr, Eli G., Klink, Andrew J., Mehta, Sonam, Gajra, Ajeet

“…Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment for relapsed or refractory large B-cell lymphoma (LBCL) with the Food and…”
Get full text

The gamification of healthcare: emergence of the digital practitioner? by Phillips, Jr, Eli G, Nabhan, Chadi, Feinberg, Bruce A

“…The application of behavioral economics principles in healthcare has been transformed through the use of technology and recently the advent of video gaming…”
Get full text

Neurological adverse events following CAR T-cell therapy: a real-world analysis by Gajra, Ajeet, Zettler, Marjorie E, Phillips Jr, Eli G, Klink, Andrew J, Jonathan K Kish, Fortier, Stephanie, Mehta, Sonam, Feinberg, Bruce A

“…To characterize real-world neurological adverse events (AEs) associated with chimeric antigen receptor T-cell therapies in patients with refractory/relapsed…”
Get full text

Application of the concept of "moral luck" in a case involving a pharmacist by Phillips, Jr, Eli G, Brushwood, David B

Get full text

Expanded Access and Right To Try Requests: The Community Oncologist's Experience by Zettler, Marjorie E, Jeune-Smith, Yolaine, Feinberg, Bruce A, Phillips, Jr, Eli G, Gajra, Ajeet

“…For patients with cancer who have exhausted approved treatment options and for whom appropriate clinical trials are not available, access to investigational…”
Get more information

Developing Effective Study Groups in the Quest for the “Holy Grail”: Critical Thinking by Linn, William D., Lord, Kevin C., Whong, Christine Y., Phillips, Eli G.

Get full text

Age-Based Disparities in Clinical Trials Supporting FDA Approval of Therapies for Hematologic Malignancies by Gajra, Ajeet, Zettler, Marjorie E, Phillips, Eli G, Feinberg, Bruce

“…Introduction: Older adults comprise the largest proportion of patients diagnosed with hematologic malignancies, with most new cases occurring in adults age 65…”
Get full text

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel by Gajra, Ajeet, Zettler, Marjorie E, Phillips Jr, Eli G, Klink, Andrew J, Kish, Jonathan K., Mehta, Sonam, Feinberg, Bruce

“…Introduction: Neurotoxicity is a major adverse event (AE) of CAR-T therapy with diverse presentation. When severe, it can be fatal, and may lead to neurologic…”
Get full text

Real-World Analysis of Adverse Events Associated with CAR T-Cell Therapy Among Adults Age ≥65 Years by Zettler, Marjorie E, Feinberg, Bruce A, Phillips Jr, Eli G, Klink, Andrew J, Mehta, Sonam, Gajra, Ajeet

“…Introduction: Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tis-cel) are chimeric antigen receptor (CAR) T-cell therapies that target CD19-expressing…”
Get full text

Developing Effective Study Groups in the Quest for the "Holy Grail": Critical Thinking by Linn, William D, Lord, Kevin C, Whong, Christine Y, Phillips, Eli G

“…There are efforts in pharmacy education to focus on active learning in the curricula to promote higher-order learning.1 Selecting the appropriate quantity of…”
Get full text

Generic liability, or lack thereof, under duty-to-warn: it's all about the labeling by Smith, W. Thomas, Phillips, Eli G., Jr

“…[...]there is very little reason to be concerned from a patient-health perspective that patients have little say in their use of generic drugs. [...]since the…”
Get full text